Chief Financial Officer · Pacira BioSciences, Inc. · Common Stock
Side
SELL
Value
$194K
Shares
7,714
Price
$25.14
Executed
Apr 20, 2026
Disclosed
Apr 22, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Apr 20 executedApr 22, 2026 disclosed
PCRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Cross Shawn filed this Form 4 reporting a open-market sale of PCRX on Apr 20, 2026. It became public on Apr 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Financial Officer
Cross Shawncik:0001734779
Issuer
Pacira BioSciences, Inc.cik:0001396814
Revision history · 0
No field has changed since this record was first ingested.
